Adenoma detection rate (ADR) is inversely correlated with postcolonoscopy (PC) CRC incidence risk in a fecal immunochemical test (FIT)-based screening program, necessitating adequate colonoscopy quality monitoring in this situation. The likelihood of PCCRC may be considerably decreased by raising endoscopists’ ADR.